Gall Bladder Cancer
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)
- Details
ClinicalTrials.gov ID:
NCT05506943
Diagnosis Type:
NA
USOR Number:
- Address
2130 NE Loop 410, Suite 100
San
Antonio, TX 78217
P: (210) 656-7177